Search

Displaying results 3031 - 3040 of 10000 in total
  1. Drug

    Rafigrelide

    go.drugbank.com/drugs/DB21285
    Experimental

    Rafigrelide is a small molecule drug. Rafigrelide has a monoisotopic molecular weight of 283.03 Da.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  2. Drug

    Adarigiline

    go.drugbank.com/drugs/DB21418
    Experimental

    Adarigiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Adarigiline is a monoamine oxydase (MAO)-inhibitor type B. … Adarigiline has a monoisotopic molecular weight of 360.08 Da.

  3. Drug

    Afizagabar

    go.drugbank.com/drugs/DB21439
    Investigational

    Afizagabar has a monoisotopic molecular weight of 365.06 Da. … Afizagabar is a small molecule drug. Afizagabar is under investigation in clinical trial NCT02877615 (Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event).

    Categories: GABA-A Receptor Antagonists, Heterocyclic Compounds, 1-Ring
  4. Drug

    Neluxicapone

    go.drugbank.com/drugs/DB21445
    Experimental

    Neluxicapone is a small molecule drug. Neluxicapone has a monoisotopic molecular weight of 264.09 Da.

  5. Drug

    Lonodelestat

    go.drugbank.com/drugs/DB21452
    Experimental

    Lonodelestat is a small molecule drug. The usage of the INN stem '-elestat' in the name indicates that Lonodelestat is a elastase inhibitor. … Lonodelestat has a monoisotopic molecular weight of 1477.82 Da.

  6. Drug

    Milategrast

    go.drugbank.com/drugs/DB21461
    Experimental

    Milategrast is a small molecule drug. Milategrast has a monoisotopic molecular weight of 354.3 Da.

  7. Drug

    MOPEVAC-Las

    go.drugbank.com/drugs/DB33987
    Experimental

    MOPEVAC-Las is a biologic drug. … MOPEVAC-Las is under investigation in clinical trial NCT07833436 (A Randomized, Placebo-controlled Trial, to Evaluate the Safety, Immunogenicity and the Optimal Dose of MOPEVAC-Las Vaccine Candidate Against

  8. Drug

    VV-14300

    go.drugbank.com/drugs/DB33996
    Experimental

    VV-14300 is a biologic drug. VV-14300 is under investigation in clinical trial NCT07829302 (VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes).

  9. Drug

    VV-14299

    go.drugbank.com/drugs/DB33997
    Experimental

    VV-14299 is a biologic drug. VV-14299 is under investigation in clinical trial NCT07829302 (VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes).

  10. Drug

    RXC008

    go.drugbank.com/drugs/DB33985
    Experimental

    RXC008 is a small molecule drug. RXC008 is under investigation in clinical trial NCT07832435 (A Phase 2, Placebo-Controlled Study of Oral RXC008 for Crohn's Strictures).